COVID-19 is an emerging, rapidly evolving siituation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Tara Hiltke, Ph.D.

Program Director

Tara Hiltke

Dr. Hiltke provides leadership and oversight to the Monoclonal Antibody Characterization program. She also works in developing other methods of antigen generation. Previously, Dr. Hiltke served as a senior scientist/project manager in assay development at both Wellstat Diagnostics and BioVeris Corporation, where she developed clinical assays for diagnostic markers using electrochemiluminescence platform and magnetic beads. Dr. Hiltke holds a Ph.D. degree (1999) in biology from the University of Buffalo.